Resistance training and reduction of treatment side effects in prostate cancer patients.
暂无分享,去创建一个
Kazunori Nosaka | Robert U Newton | Nigel Spry | Michael R McGuigan | R. Newton | Katsuhiko Suzuki | D. Galvão | N. Spry | K. Nosaka | D. Taaffe | M. McGuigan | L. Kristjanson | K. Yamaya | Linda J Kristjanson | Katsuhiko Suzuki | Daniel A Galvão | Dennis R Taaffe | Kanemitsu Yamaya
[1] W. Dahut,et al. Androgen deprivation therapy for prostate cancer. , 2005, JAMA.
[2] C. Higano,et al. Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy , 2004, Cancer.
[3] R. Newton,et al. Review of exercise intervention studies in cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] C. Pashos,et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] T. Abe,et al. Time course for strength and muscle thickness changes following upper and lower body resistance training in men and women , 2000, European Journal of Applied Physiology.
[6] Anthony L Zietman,et al. Changes in body composition during androgen deprivation therapy for prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.
[7] J. Goodwin,et al. Risk of fracture after androgen deprivation for prostate cancer. , 2005, The New England journal of medicine.
[8] M. Scholz,et al. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. , 1997, British journal of urology.
[9] T. DeWeese,et al. Long‐term effects of androgen deprivation therapy in prostate cancer patients , 2002, Clinical endocrinology.
[10] R. Parker,et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. , 2001, The Journal of clinical endocrinology and metabolism.
[11] L. Lipsitz,et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. , 1990, JAMA.
[12] J. Finkelstein,et al. Changes in bone mineral density and body composition during initial and long‐term gonadotropin‐releasing hormone agonist treatment for prostate carcinoma , 2005, Cancer.
[13] K. Courneya,et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Marcus,et al. Once‐Weekly Resistance Exercise Improves Muscle Strength and Neuromuscular Performance in Older Adults , 1999, Journal of the American Geriatrics Society.
[15] H. Wallmann,et al. Comparison of elderly nonfallers and fallers on performance measures of functional reach, sensory organization, and limits of stability. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] D. Galvão,et al. Resistance Exercise Dosage in Older Adults: Single‐ Versus Multiset Effects on Physical Performance and Body Composition , 2005, Journal of the American Geriatrics Society.
[17] J. Goodwin,et al. Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma , 2005, Cancer.
[18] J. Cauley,et al. Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: cross-sectional associations in the Health ABC Study. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[19] D G Sale,et al. Neural adaptation to resistance training. , 1988, Medicine and science in sports and exercise.
[20] Robert U Newton,et al. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. , 2011, Medicine and science in sports and exercise.
[21] P. Kantoff,et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. , 2001, The New England journal of medicine.
[22] Matthew R. Smith. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. , 2004, Urology.
[23] J. Nelson,et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. , 2005, The Journal of clinical endocrinology and metabolism.
[24] K. Courneya. Exercise in cancer survivors: an overview of research. , 2003, Medicine and science in sports and exercise.
[25] R. Newton,et al. Anabolic responses to resistance training in older men and women: a brief review. , 2005, Journal of aging and physical activity.
[26] D. Taaffe. Sarcopenia--exercise as a treatment strategy. , 2006, Australian family physician.
[27] A. Dobs,et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy , 2006, Cancer.
[28] M. Cooperberg,et al. The changing face of prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Strength conditioning in older men: skeletal muscle hypertrophy and improved function. , 1988 .